SCHEMBL13870906

SCHEMBL13870906

Cc1ccc(-c2ccc3cc(C)c(C)cc3n2)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
MAPT P10636 5/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TLR8 Q9NR97 1/20 0.40
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 3/20 0.40
ALPL P05186 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CA9 Q16790 1/20 0.40
TSHR P16473 2/20 0.39
ALOX15 P16050 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AR P10275 1/20 0.38
NPC1 O15118 2/20 0.38
NCK1 P16333 1/20 0.38
BACE1 P56817 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP17A1 P05093 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13989405 0.89 CYP1A2 (0.53) CYP1A2MAPTNPSR1TLR8ALDH1A1
SCHEMBL13298969 0.87 CYP1A2 (0.55) CYP1A2MAPTNPSR1TLR8ALDH1A1
SCHEMBL13870905 0.86 CYP1A2 (0.41) CYP1A2MAPTNPSR1TLR8ALDH1A1
SCHEMBL13870957 0.84 KMT2A (0.41) CYP1A2MAPTNPSR1TLR8ALDH1A1
SCHEMBL13870937 0.83 PDGFRB (0.47) CYP1A2MAPTNPSR1ALDH1A1KDM4E
SCHEMBL13870908 0.83 NQO2 (0.43) CYP1A2MAPTALDH1A1KDM4EHSD17B10
SCHEMBL4439950 0.81 AR (0.53) CYP1A2MAPTNPSR1ALDH1A1KDM4E
SCHEMBL18774770 0.81 AR (0.57) CYP1A2MAPTALDH1A1KDM4EHSD17B10
SCHEMBL13989400 0.80 CYP1A2 (0.52) CYP1A2MAPTNPSR1ALDH1A1KDM4E
SCHEMBL4137217 0.79 CYP1A2 (0.42) CYP1A2MAPTNPSR1TLR8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 CYP1A2 3387/4885MAPT 1550/4885NPSR1 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.